Insulin Glargin

DRUG2 trials

Sponsors

Heidelberg University, ikfe-CRO GmbH

Conditions

Insufficient Metabolic ControlOAD TreatmentType 2 DiabetesType 2 Diabetic Patients

Phase 4

Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells

Heidelberg UniversityType 2 Diabetes

Start: 2007-08-31End: 2010-05-31Target: 75Updated: 2009-02-13

Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin

CompletedNCT00941148

ikfe-CRO GmbHInsufficient Metabolic Control, OAD Treatment, Type 2 Diabetic Patients

Start: 2008-04-30End: 2009-03-31Updated: 2009-07-17

Related Papers

Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study.

2014-10-1115 citations